$EKSO
EKSO BIONICS HOLDINGS, INC. Stock $ekso

$ekso Overview Financials Valuation SEC Filings Company Website

2016 Form 10-K Financial Statement

#000114420417014588 Filed on March 15, 2017

Income Statement

Concept	2016	2015 Q4	2015 Q3
Revenue	$14.22M	$1.943M	$2.915M
YoY Change	64.2%	31.28%	83.56%
Cost Of Revenue	$11.27M	$2.140M	$2.447M
YoY Change	50.68%	130.11%	120.85%
Gross Profit	$2.947M	-$194.0K	$468.0K
YoY Change	149.96%	-135.02%	-2.5%
Gross Profit Margin	20.72%	-9.98%	16.05%
Selling, General & Admin	$21.85M	$4.420M	$3.936M
YoY Change	34.38%	7.54%	26.32%
% of Gross Profit	741.43%		841.03%
Research & Development	$8.879M	$2.040M	$1.713M
YoY Change	37.02%	56.92%	56.3%
% of Gross Profit	301.29%		366.03%
Depreciation & Amortization	$1.855M	$280.0K	$230.0K
YoY Change	98.82%	33.33%	9.52%
% of Gross Profit	62.95%		49.15%
Operating Expenses	$30.53M	$6.460M	$5.649M
YoY Change	34.27%	19.41%	34.12%
Operating Profit	-$27.59M	-$6.654M	-$5.181M
YoY Change	27.94%	37.03%	38.83%
Interest Expense	$16.00K	$0.00	$4.000K
YoY Change	23.08%		33.33%
% of Operating Profit
Other Income/Expense, Net	$4.116M	$2.010M	-$2.000K
YoY Change	108.83%	-113.14%	-86.67%
Pretax Income	-$21.46M	-$4.650M	-$5.190M
YoY Change	7.73%	-76.92%	-143.18%
Income Tax
% Of Pretax Income
Net Earnings	-$23.47M	-$4.645M	-$5.185M
YoY Change	19.81%	-76.95%	-143.12%
Net Earnings / Revenue	-165.04%	-239.06%	-177.87%
Basic Earnings Per Share	-$1.87		-$0.35
Diluted Earnings Per Share	-$2.05	-$4.745M	-$0.35
COMMON SHARES
Basic Shares Outstanding	18.13M shares	102.1M shares	14.61M shares
Diluted Shares Outstanding	18.62M shares		14.61M shares

Balance Sheet

Concept	2016	2015 Q4	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.85M	$19.55M	$11.24M
YoY Change	-13.81%	-22.39%	56.55%
Cash & Equivalents		$19.55M	$11.24M
Short-Term Investments
Other Short-Term Assets	$500.0K	$2.530M	$2.650M
YoY Change	-80.24%	30.41%	55.88%
Inventory	$1.560M	$1.056M	$1.179M
Prepaid Expenses
Receivables	$1.780M	$2.069M	$2.185M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$20.68M	$25.20M	$17.25M
YoY Change	-17.94%	-13.99%	47.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.440M	$2.625M	$2.399M
YoY Change	-7.22%	24.88%	22.57%
Goodwill		$189.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$90.00K	$97.00K	$55.00K
YoY Change	-96.54%		0.43%
Total Long-Term Assets	$3.750M	$6.997M	$4.878M
YoY Change	-46.43%	67.63%	29.87%
TOTAL ASSETS
Total Short-Term Assets	$20.68M	$25.20M	$17.25M
Total Long-Term Assets	$3.750M	$6.997M	$4.878M
Total Assets	$24.43M	$32.20M	$22.13M
YoY Change	-24.13%	-3.81%	43.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.880M	$2.694M	$2.148M
YoY Change	-30.11%	244.06%	99.43%
Accrued Expenses	$2.610M	$1.885M	$2.190M
YoY Change	51.74%	-20.73%	65.66%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$50.00K	$80.00K	$80.00K
YoY Change	-37.5%	100.0%	100.0%
Total Short-Term Liabilities	$6.310M	$8.619M	$8.256M
YoY Change	-26.8%	30.31%	40.03%
LONG-TERM LIABILITIES
Long-Term Debt	$6.790M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$4.790M	$195.0K	$4.620M
YoY Change	-67.57%	18.18%	-69.92%
Total Long-Term Liabilities	$11.58M	$195.0K	$4.620M
YoY Change	-21.6%	18.18%	-70.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.310M	$8.619M	$8.256M
Total Long-Term Liabilities	$11.58M	$195.0K	$4.620M
Total Liabilities	$17.89M	$23.39M	$12.88M
YoY Change	-23.51%	119.13%	-39.64%
SHAREHOLDERS EQUITY
Retained Earnings		-$91.39M	-$86.75M
YoY Change		27.28%	67.96%
Common Stock		$15.00K	$102.0K
YoY Change		-85.29%	29.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.530M	$8.808M	$9.246M
YoY Change
Total Liabilities & Shareholders Equity	$24.43M	$32.20M	$22.13M
YoY Change	-24.13%	-3.81%	43.51%

Cashflow Statement

Concept	2016	2015 Q4	2015 Q3
OPERATING ACTIVITIES
Net Income	-$23.47M	-$4.645M	-$5.185M
YoY Change	19.81%	-76.95%	-143.12%
Depreciation, Depletion And Amortization	$1.855M	$280.0K	$230.0K
YoY Change	98.82%	33.33%	9.52%
Cash From Operating Activities	-$25.00M	-$5.190M	-$4.620M
YoY Change	36.83%	91.51%	28.69%
INVESTING ACTIVITIES
Capital Expenditures	$1.096M	-$530.0K	-$400.0K
YoY Change	-26.54%	-7.02%	60.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$1.096M	-$530.0K	-$400.0K
YoY Change	-26.54%	-22.06%	66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$14.69M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$23.31M	14.03M	10.00K
YoY Change	65.02%	-34.44%	-75.0%
NET CHANGE
Cash From Operating Activities	-$25.00M	-5.190M	-4.620M
Cash From Investing Activities	-$1.096M	-530.0K	-400.0K
Cash From Financing Activities	$23.31M	14.03M	10.00K
Net Change In Cash	-$2.786M	8.310M	-5.010M
YoY Change	-50.58%	-53.86%	32.19%
FREE CASH FLOW
Cash From Operating Activities	-$25.00M	-$5.190M	-$4.620M
Capital Expenditures	$1.096M	-$530.0K	-$400.0K
Free Cash Flow	-$26.09M	-$4.660M	-$4.220M
YoY Change	32.04%	117.76%	26.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014	us-gaap	Gross Profit GrossProfit	1559000	USD
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9258000	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2015Q4	us-gaap	Deferred Costs DeferredCosts	2502000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	91000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	97000	USD
CY2016Q4	us-gaap	Assets Assets	24425000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2435000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2625000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6480000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016	us-gaap	Gross Profit GrossProfit	2947000	USD
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7085000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3868000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7002000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-33769000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-38101000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.66
CY2016	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10997000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3556000	USD
CY2015Q4	us-gaap	Assets Assets	32198000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1879000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2694000	USD
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2403000	USD
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	887000	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	8661000	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	5327000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1885000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2069000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	189000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	825000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3960000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	54000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	25201000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6314000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8619000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	805000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4613000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	195000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	17894000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	23390000	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	22000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	15000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121291000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100185000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-114861000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-91391000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	6531000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	8808000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24425000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32198000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	20684000	USD
CY2015Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	2088000	USD
CY2016Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	436000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	502000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	1056000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	1556000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1780000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19552000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16846000	USD
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	80000	USD
CY2016Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1026000	USD
CY2015Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1584000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	189000	USD
CY2015Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	9195000	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3546000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	217000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	13334000	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	14221000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3926000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2048000	USD
CY2015	us-gaap	Cost Of Services CostOfServices	3556000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4252000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2924000	USD
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4409000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8879000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7400000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	22740000	USD
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11274000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-27586000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	18353000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	30533000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10853000	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	282000	USD
CY2014Q1	ekso	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	27324000	USD
CY2014Q1	ekso	Stock Issued During Period Value Private Placement Offering StockIssuedDuringPeriodValuePrivatePlacementOffering	25300000	USD
CY2014Q1	ekso	Private Placement Offering Stock Issued During Period Value Conversion Of Debt PrivatePlacementOfferingStockIssuedDuringPeriodValueConversionOfDebt	5082000	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	USD
CY2014Q1	ekso	Adjustments To Additional Paid In Capital Fair Value Of Warrant Obligation Transferred To Equity AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantObligationTransferredToEquity	96000	USD
CY2014Q1	ekso	Adjustments To Additional Paid In Capital Decrease Due To Unamortized Debt Discounts Transferred To Equity AdjustmentsToAdditionalPaidInCapitalDecreaseDueToUnamortizedDebtDiscountsTransferredToEquity	947000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-21561000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-16794000	USD
CY2015	us-gaap	Interest Expense InterestExpense	13000	USD
CY2014	us-gaap	Interest Expense InterestExpense	435000	USD
CY2016	us-gaap	Interest Expense InterestExpense	16000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-45000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-61000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-166000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1971000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16975000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4116000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-19590000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-33769000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-23470000	USD
CY2015	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	4655000	USD
CY2014	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	0	USD
CY2016	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	10345000	USD
CY2016	ekso	Warrant Issuance Expense WarrantIssuanceExpense	0	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33769000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33815000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24245000	USD
CY2014	ekso	Warrant Issuance Expense WarrantIssuanceExpense	0	USD
CY2015	ekso	Warrant Issuance Expense WarrantIssuanceExpense	487000	USD
CY2016	ekso	Gain Loss On Warrant Liability GainLossOnWarrantLiability	4286000	USD
CY2014	ekso	Gain Loss On Warrant Liability GainLossOnWarrantLiability	-16485000	USD
CY2015	ekso	Gain Loss On Warrant Liability GainLossOnWarrantLiability	2505000	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3339000	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	10614000	USD
	ekso	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	21412000	USD
	ekso	Adjustments To Additional Paid In Capital Fair Value Of Warrant Liability Transferred To Equity Upon Removal Of Antidilution Clause AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantLiabilityTransferredToEquityUponRemovalOfAntidilutionClause	27099000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	102000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1143000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33769000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	225000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1731000	USD
CY2015	ekso	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	53000	USD
CY2015	ekso	Convertible Preferred Stock Beneficial Conversion Feature ConvertiblePreferredStockBeneficialConversionFeature	4655000	USD
CY2015	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1071000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3300000	USD
CY2015	ekso	Stock Issued During Period Value Conversion Of Preferred Stock To Common Stock And Accretion Of Preferred Discount StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockAndAccretionOfPreferredDiscount	1356000	USD
CY2015	us-gaap	Depreciation Depreciation	933000	USD
CY2014	us-gaap	Depreciation Depreciation	745000	USD
CY2016	us-gaap	Depreciation Depreciation	1855000	USD
CY2015	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	-37000	USD
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	30000	USD
CY2015	us-gaap	Inventory Write Down InventoryWriteDown	34000	USD
CY2014	us-gaap	Inventory Write Down InventoryWriteDown	-36000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-818000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2706000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25190000	USD
CY2014	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	-36000	USD
CY2016	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	-36000	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	208000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2015	us-gaap	Accretion Expense AccretionExpense	0	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	1143000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	3121000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	520000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-154000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	200000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-354000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	541000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	91000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	36000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	60000	USD
CY2015	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	1022000	USD
CY2014	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	1995000	USD
CY2016	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-4590000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1738000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-716000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-493000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	944000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1468000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1266000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2679000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-6943000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-18269000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15007000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	1731000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1487000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1096000	USD
CY2015	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	13906000	USD
CY2014	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	225000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	102000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	110000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5638000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	24385000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	805000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	12000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	138000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	16000	USD
CY2015	us-gaap	Interest Paid InterestPaid	5000	USD
CY2014	us-gaap	Interest Paid InterestPaid	38000	USD
CY2016	us-gaap	Interest Income Other InterestIncomeOther	0	USD
CY2014	us-gaap	Interest Income Other InterestIncomeOther	-3000	USD
CY2015	us-gaap	Interest Income Other InterestIncomeOther	0	USD
CY2016	us-gaap	Accretion Expense AccretionExpense	0	USD
CY2015	ekso	Conversionofbridgeloantocommonstock Conversionofbridgeloantocommonstock	0	USD
CY2014	ekso	Conversionofbridgeloantocommonstock Conversionofbridgeloantocommonstock	5082000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	1000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	25000	USD
CY2014	us-gaap	Accretion Expense AccretionExpense	20000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24997000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1492000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1487000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1096000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1492000	USD
CY2016	us-gaap	Interest Paid InterestPaid	33000	USD
CY2015	ekso	Acquisitionofpropertyandequipmentwithcapitallease Acquisitionofpropertyandequipmentwithcapitallease	166000	USD
CY2014	ekso	Acquisitionofpropertyandequipmentwithcapitallease Acquisitionofpropertyandequipmentwithcapitallease	0	USD
CY2016	ekso	Acquisitionofpropertyandequipmentwithcapitallease Acquisitionofpropertyandequipmentwithcapitallease	0	USD
CY2015	ekso	Beneficial Conversion Feature On Issuance Of Preferred Stock BeneficialConversionFeatureOnIssuanceOfPreferredStock	4655000	USD
CY2014	ekso	Beneficial Conversion Feature On Issuance Of Preferred Stock BeneficialConversionFeatureOnIssuanceOfPreferredStock	0	USD
CY2016	ekso	Beneficial Conversion Feature On Issuance Of Preferred Stock BeneficialConversionFeatureOnIssuanceOfPreferredStock	10345000	USD
CY2015	ekso	Issuance Of Preferred Stock Warrants IssuanceOfPreferredStockWarrants	11700000	USD
CY2014	ekso	Issuance Of Preferred Stock Warrants IssuanceOfPreferredStockWarrants	0	USD
CY2016	ekso	Issuance Of Preferred Stock Warrants IssuanceOfPreferredStockWarrants	0	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	1839000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0	USD
CY2016	ekso	Conversionofbridgeloantocommonstock Conversionofbridgeloantocommonstock	0	USD
CY2015	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2014	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	27324000	USD
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	3000	USD
CY2015	ekso	Conversionofpreferredstockwarrantstocommonstockwarrants Conversionofpreferredstockwarrantstocommonstockwarrants	0	USD
CY2014	ekso	Conversionofpreferredstockwarrantstocommonstockwarrants Conversionofpreferredstockwarrantstocommonstockwarrants	282000	USD
CY2016	ekso	Conversionofpreferredstockwarrantstocommonstockwarrants Conversionofpreferredstockwarrantstocommonstockwarrants	0	USD
CY2015	ekso	Transferofwarrantliabilitytoequity Transferofwarrantliabilitytoequity	0	USD
CY2014	ekso	Transferofwarrantliabilitytoequity Transferofwarrantliabilitytoequity	27099000	USD
CY2016	ekso	Transferofwarrantliabilitytoequity Transferofwarrantliabilitytoequity	1363000	USD
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	60000	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2596000	USD
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	79000	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	53000	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	21412000	USD
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1825000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21961000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14694000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	14124000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	40879000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	23307000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	104000	USD
CY2015	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-2505000	USD
CY2014	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2016	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-4286000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-26750000	USD
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.83
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.02
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.05
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.02
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2014Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	7.00
CY2015	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	1839000	USD
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3513000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4440000	shares
CY2016Q4	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value Low BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow	157000	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5802000	shares
CY2014	ekso	Stock Issued During Period Shares Acquisitions Previously Held StockIssuedDuringPeriodSharesAcquisitionsPreviouslyHeld	643000	shares
CY2014	ekso	Stock Issued During Period Shares Acquisitions New Issues StockIssuedDuringPeriodSharesAcquisitionsNewIssues	111000	shares
CY2014	ekso	Equity Interest EquityInterest	0.068	pure
CY2014Q1	ekso	Equity Issued During Period Units New Issues EquityIssuedDuringPeriodUnitsNewIssues	1389000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	224000	shares
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-21458000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	198000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	328000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	113000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2058000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	31000	shares
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	336000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	948000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1506000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	813000	shares
CY2016Q4	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	521000	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	1750000	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value Low BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow	3000000	USD
CY2016	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.15	pure
CY2016Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	40000	USD
CY2016Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	1610000	USD
CY2016Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	1650000	USD
CY2016Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	1839000	USD
CY2015	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	1610000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	558000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	9434000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5449000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-19590000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-33978000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1193000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	783000	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	102000	USD
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	82000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	267000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3376000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2253000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	933000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	745000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1855000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2349000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1464000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	56000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	257000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	203000	USD
CY2015Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	110000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	164000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	342000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	343000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	400000	USD
CY2015Q4	ekso	Gross Proceeds From Preferred Stock And Warrants GrossProceedsFromPreferredStockAndWarrants	15000000	USD
CY2015Q4	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	13906000	USD
CY2015Q4	ekso	Stock Related Expenses Payable StockRelatedExpensesPayable	173000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2012000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19590000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-33637000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-23470000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-19918000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-33750000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35647000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26826000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	872000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	530000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40125000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29298000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	246000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2430000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	86000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	168000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	61000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	951000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	317000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	693000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1222000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	43000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	220000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	113000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10827000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7983000	USD
CY2014	ekso	Unrecognized Tax Benefits Increases Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromCurrentPeriodTaxPositions	46000	USD
CY2015	ekso	Unrecognized Tax Benefits Increases Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromCurrentPeriodTaxPositions	75000	USD
CY2014	ekso	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	4000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	143000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	199000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	1689000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	2114000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	2915000	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1943000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	8486000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	1552000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	403000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	502000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	468000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	-194000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	1498000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	203000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	403000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	843000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.63
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-3651000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-5765000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-8478000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-5576000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21902212	shares
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	79000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	107000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	93000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	13000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	13000	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5185000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9300000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-4115000	USD
CY2016	dei	Document Type DocumentType	10-K
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	71429000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	71429000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21894000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21894000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15027000	shares
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6775000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9970000	USD
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Entity Registrant Name EntityRegistrantName	EKSO BIONICS HOLDINGS, INC.
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001549084
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	58706755	USD
CY2016	dei	Trading Symbol TradingSymbol	EKSO
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1596000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	2587000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-5645000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-5185000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-4645000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4115000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5645000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11494000	USD
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5576000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	80000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33735000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	918000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	9085000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	1050000	USD
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2016	ekso	Convertible Preferred Stock Beneficial Conversion Feature ConvertiblePreferredStockBeneficialConversionFeature	10345000	USD
CY2016	ekso	Stock Issued During Period Value Conversion Of Preferred Stock To Common Stock And Accretion Of Preferred Discount StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockAndAccretionOfPreferredDiscount	10345000	USD
CY2016Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2477000	shares
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.015	pure
CY2016	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y5M12D
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.009	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.005	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.003	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.408	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.384	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.189	pure
CY2016	ekso	Unrecognized Tax Benefits Increases Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromCurrentPeriodTaxPositions	132000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	335000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	93000	USD
CY2015	ekso	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	-19000	USD
CY2015	ekso	Adjustments To Additional Paid In Capital Issuance Of Warrants AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrants	11700000	USD
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.002	pure
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3121000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	110000	USD
CY2016	ekso	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	3188000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24246000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33769000	USD
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18126000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14606000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11181000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18622000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14609000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11181000	shares
CY2016	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	80000	USD
CY2016	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	80000	USD
CY2016Q4	us-gaap	Contractual Obligation ContractualObligation	11053000	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.010	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.002	pure
CY2015	ekso	Effective Income Tax Rate Reconciliation Unrealized Gain Loss On Warrant EffectiveIncomeTaxRateReconciliationUnrealizedGainLossOnWarrant	0.043	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.004	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.005	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.001	pure
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001	pure
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2016	ekso	Effective Income Tax Rate Reconciliation Unrealized Gain Loss On Warrant EffectiveIncomeTaxRateReconciliationUnrealizedGainLossOnWarrant	0.062	pure
CY2016	ekso	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	4000	USD
CY2016Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	6.50
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1731000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1143000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1262000	shares
CY2016Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	5.97
CY2016	ekso	Change In Fair Value Contingent Consideration ChangeInFairValueContingentConsideration	196000	USD
CY2015	ekso	Change In Fair Value Contingent Consideration ChangeInFairValueContingentConsideration	0	USD
CY2014	ekso	Change In Fair Value Contingent Consideration ChangeInFairValueContingentConsideration	0	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3121000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0124	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0237	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0141	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0250	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0097	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0261	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.77	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.83	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.73	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.76	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.66	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.75	pure
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Use of Estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of associated costs, valuation of acquired intangible assets and goodwill, useful lives assigned to long-lived assets, realizability of deferred tax assets, valuation of common and preferred stock warrants, the valuation of options, and contingencies. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	103000	USD
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> Concentration of Credit Risk and Other Risks and Uncertainties</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains our cash accounts in excess of federally insured limits. However, the Company believes it is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held.  The Company extends credit to customers in the normal course of business and performs ongoing credit evaluations of its customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. The Company does not require collateral from its customers to secure accounts receivable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and provides an allowance for credit losses, as needed. The Company has not experienced material losses related to accounts receivable during the years ended December 31, 2016 and December 31, 2015. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. The Company does not enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has not experienced significant gains or losses upon settling foreign contracts.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">At December 31, 2016, the Company had three customers with accounts receivable balances totaling <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% or more of the Company’s total accounts receivable (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">18</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>%) compared with one customer at December 31, 2015 (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10</font>%) and two customers at December 31, 2014 (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">22</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>%).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">For the year ended December 31, 2016, the Company had no customers with billed revenue of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% or more of the Company’s total customer revenue, compared with one customer for the year ended December 31, 2015 (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">33</font>%) and one customer for the year ended December 31, 2014 (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12</font>%).</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	1630000	USD
CY2015Q4	us-gaap	Deferred Revenue DeferredRevenue	8573000	USD
CY2016Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0	USD
CY2015Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	4590000	USD
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	496000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3000	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	411000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	156000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	12000	USD
CY2016Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	144000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	90000	USD
CY2016	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P5Y
CY2016	us-gaap	Lessee Leasing Arrangements Operating Leases Renewal Term LesseeLeasingArrangementsOperatingLeasesRenewalTerm	P5Y
CY2015	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3597000	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4085000	shares
CY2016	ekso	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	488000	shares
CY2016	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	1071000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	768000	USD
CY2016	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	1839000	USD
CY2016	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y
CY2016	ekso	Expiration Date Of Buyout Payment Provision ExpirationDateOfBuyoutPaymentProvision	2017-11-30
CY2016	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	135000	USD
CY2016Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	267	shares
CY2016Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	921000	shares
CY2016Q4	us-gaap	Inventory Gross InventoryGross	1658000	USD
CY2015Q4	us-gaap	Inventory Gross InventoryGross	1138000	USD
CY2016	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1389000	shares
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5811000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4878000	USD
CY2016Q4	ekso	Accrued Maintenance Current AccruedMaintenanceCurrent	483000	USD
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	173000	USD
CY2015	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2014	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	6930000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	80000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1000	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2016	ekso	Transfer Of Property And Equipment To Inventory TransferOfPropertyAndEquipmentToInventory	11000	USD
CY2015	ekso	Transfer Of Property And Equipment To Inventory TransferOfPropertyAndEquipmentToInventory	0	USD
CY2014	ekso	Transfer Of Property And Equipment To Inventory TransferOfPropertyAndEquipmentToInventory	0	USD
CY2016	ekso	Contingent Success Fee Liability For Term Loan ContingentSuccessFeeLiabilityForTermLoan	116000	USD
CY2015	ekso	Contingent Success Fee Liability For Term Loan ContingentSuccessFeeLiabilityForTermLoan	0	USD
CY2014	ekso	Contingent Success Fee Liability For Term Loan ContingentSuccessFeeLiabilityForTermLoan	0	USD
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	500000	USD
CY2016Q4	us-gaap	Business Acquisition Share Price BusinessAcquisitionSharePrice	7.00
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26000	USD
CY2016Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	11700000	USD
CY2015Q4	ekso	Preferred Stock Converted Into Common Stock PreferredStockConvertedIntoCommonStock	3300000	shares
CY2015Q4	ekso	Accrued Maintenance Current AccruedMaintenanceCurrent	0	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	355000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2015Q4	ekso	Product Maintenance Warranty Liabilities Current Noncurrent ProductMaintenanceWarrantyLiabilitiesCurrentNoncurrent	0	USD
CY2016	ekso	Product Maintenance Warranty Addition ProductMaintenanceWarrantyAddition	1341000	USD
CY2016	ekso	Product Maintenance Warranty Expense ProductMaintenanceWarrantyExpense	-654000	USD
CY2016Q4	ekso	Product Maintenance Warranty Liabilities Current Noncurrent ProductMaintenanceWarrantyLiabilitiesCurrentNoncurrent	687000	USD
CY2016Q4	ekso	Product Maintenance Warranty Liabilities Current ProductMaintenanceWarrantyLiabilitiesCurrent	686000	USD
CY2016Q4	ekso	Product Maintenance Warranty Liabilities Noncurrent ProductMaintenanceWarrantyLiabilitiesNoncurrent	1000	USD
CY2014Q4	ekso	Product Maintenance Warranty Liabilities Current Noncurrent ProductMaintenanceWarrantyLiabilitiesCurrentNoncurrent	126000	USD
CY2015	ekso	Product Maintenance Warranty Expense ProductMaintenanceWarrantyExpense	126000	USD
CY2016	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	911000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2139000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2333000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2333000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	195000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	7000000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	211000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	6789000	USD
CY2016Q4	us-gaap	Share Price SharePrice	8.00
CY2016Q4	ekso	Contingent Success Fee Liability ContingentSuccessFeeLiability	116000	USD
CY2016Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0627	pure
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1355000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-36373000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	-8765000	USD
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15027000	shares
CY2016Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	6789000	USD
CY2015Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2016Q4	ekso	Business Combination Contingent Success Fee Liability BusinessCombinationContingentSuccessFeeLiability	116000	USD
CY2015Q4	ekso	Business Combination Contingent Success Fee Liability BusinessCombinationContingentSuccessFeeLiability	0	USD
CY2016Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	60000	USD
CY2015Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	71000	USD
CY2016	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-7 reverse
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14218000	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14694000	USD
CY2016	ekso	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits	0	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	6813000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	22800000	USD
CY2016Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	0	USD
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3000	shares
CY2014Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	89000	shares
CY2016	ekso	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	7.07
CY2015	ekso	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	7.07
CY2015	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	779000	USD
CY2016	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	1373000	USD
CY2016	ekso	Success Fee Expenses SuccessFeeExpenses	250000	USD
CY2016Q4	ekso	Unrestricted Cash And Cash Equivalents UnrestrictedCashAndCashEquivalents	10820000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	60000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	37000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	37000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	22000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD

Files In Submission

Name	View Source	Status
0001144204-17-014588-index-headers.html	Edgar Link	pending
0001144204-17-014588-index.html	Edgar Link	pending
0001144204-17-014588.txt	Edgar Link	pending
0001144204-17-014588-xbrl.zip	Edgar Link	pending
ekso-20161231.xml	Edgar Link	completed
ekso-20161231.xsd	Edgar Link	pending
ekso-20161231_cal.xml	Edgar Link	unprocessable
ekso-20161231_def.xml	Edgar Link	unprocessable
ekso-20161231_lab.xml	Edgar Link	unprocessable
ekso-20161231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pg36img1_10k.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v460534_10k.htm	Edgar Link	pending
v460534_ex21-1.htm	Edgar Link	pending
v460534_ex23-1.htm	Edgar Link	pending
v460534_ex31-1.htm	Edgar Link	pending
v460534_ex31-2.htm	Edgar Link	pending
v460534_ex32-1.htm	Edgar Link	pending
v460534_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EKSO
EKSO BIONICS HOLDINGS, INC. Stock $ekso

2016 Form 10-K Financial Statement

#000114420417014588 Filed on March 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EKSO EKSO BIONICS HOLDINGS, INC. Stock $ekso

2016 Form 10-K Financial Statement

#000114420417014588 Filed on March 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EKSO
EKSO BIONICS HOLDINGS, INC. Stock $ekso